ScholarGate
Assistent

Inherited Bleeding Disorders (Hemophilia, von Willebrand Disease, Factor Deficiencies)

Inherited bleeding disorders are genetic conditions in which a deficiency or dysfunction of a hemostatic protein produces a lifelong tendency to bleed. This topic groups the major hereditary coagulopathies — hemophilia A and B, von Willebrand disease, and the rarer single-factor deficiencies — and describes how they are categorized and identified through laboratory testing within hematopathology.

Find emne med PaperMindSnartFind papers & topics
Tools & resources
Hent slides
Learn & explore
VideoSnart

Definition

Inherited bleeding disorders are heritable defects in the quantity or function of platelets or coagulation proteins — most commonly factor VIII, factor IX, or von Willebrand factor — that impair clot formation and cause a constitutional bleeding tendency.

Scope

The entry covers the genetic and biochemical basis of these disorders, their characteristic bleeding patterns, and the laboratory approach used to distinguish them (screening assays, von Willebrand factor and factor activity measurement). It is a reference orientation to the disease category; specific named entities are also detailed in dedicated neighboring entries, and the topic gives no dosing or individualized management advice.

Core questions

  • How does the inheritance pattern (X-linked versus autosomal) shape who is affected by each disorder?
  • How do the bleeding phenotypes of platelet-type and coagulation-factor-type defects differ?
  • Which laboratory tests separate hemophilia A, hemophilia B, and von Willebrand disease?
  • How are disease severity and subtype classified from factor levels and functional assays?

Key concepts

  • X-linked inheritance of hemophilia A and B
  • Factor VIII deficiency (hemophilia A) and factor IX deficiency (hemophilia B)
  • von Willebrand factor and its role in platelet adhesion
  • Quantitative versus qualitative von Willebrand disease subtypes
  • Rare autosomal factor deficiencies
  • Factor inhibitors as a complication
  • Severity grading from residual factor activity

Mechanisms

Hemophilia A and B result from mutations in the X-linked genes encoding factor VIII and factor IX, respectively, so deficient activity impairs the intrinsic pathway and prolongs the aPTT while the PT remains normal; the residual factor level broadly tracks bleeding severity. Von Willebrand disease arises from quantitative or qualitative defects in von Willebrand factor, a protein that mediates platelet adhesion to injured vessel walls and also stabilizes circulating factor VIII; its subtypes are defined by whether the protein is reduced, dysfunctional, or absent. Rarer inherited deficiencies of other factors produce variable bleeding. Laboratory diagnosis combines screening clotting times, specific factor activity assays, and von Willebrand factor antigen and activity testing, with mixing studies used to detect inhibitors that can develop against transfused factor.

Clinical relevance

These disorders account for much of the inherited bleeding seen in clinical hematology, and their laboratory classification guides recognition and surveillance. This entry describes the category and its diagnostic logic as reference material; it is not a treatment guide, and management of any individual requires specialist hematology care.

Epidemiology

Hemophilia A is the most common severe inherited coagulation-factor deficiency and is markedly more frequent than hemophilia B, both being X-linked and therefore predominantly affecting males. Von Willebrand disease is generally regarded as the most common inherited bleeding disorder overall, though many cases are mild; the other single-factor deficiencies are individually rare.

History

Hemophilia has been recognized for centuries, famously through its transmission among European royal families, and became a paradigm for X-linked inheritance. The mid-twentieth-century mapping of the coagulation cascade allowed the distinct factor deficiencies to be separated, and the later cloning of the factor VIII and von Willebrand factor genes refined classification and enabled molecular diagnosis, a trajectory summarized in the historical reviews of the hemophilias.

Key figures

  • Pier Mannucci
  • Edward Tuddenham
  • Robert Macfarlane

Related topics

Seminal works

  • macfarlane-1964
  • ng-versteeg-2015
  • james-2021

Frequently asked questions

What is the difference between hemophilia A and hemophilia B?
Both are X-linked deficiencies that prolong the aPTT, but hemophilia A is caused by deficient factor VIII and hemophilia B by deficient factor IX. They are distinguished by specific factor activity assays, since their clinical pictures can be similar.
Why is von Willebrand disease often considered the most common inherited bleeding disorder?
Von Willebrand factor abnormalities are relatively frequent in the population, though many cases are mild and may go undetected. The disease affects platelet adhesion and can also lower factor VIII levels.

Methods for this concept

Related concepts